Biotech Stock News (RXII) (GNCA)

Rxi Pharmaceuticals (NASDAQ:RXII) On Thursday March 31, 2016 Rxi Pharmaceuticals announced that it had received a patent from the United States Patent and Trademark Office — USPTO — for the company’s sd-rxRNA technology platform that covers CTGF — Connective Tissue Growth Factor. In essence the patent covers the company’s lead clinical product RXI-109, which is … Read more

Biotech Stock News (NYMX) (GALE) (SGYP)

Nymox Pharmaceutical (NASDAQ:NYMX) On July 27, 2015 Nymox surged as high as 100% after the company reported positive phase 3 results for its BPH study. BPH stands for benign prostatic hyperplasia, and is characterized by an enlarged prostate gland. This enlarged prostate gland causes problems such as problems of urinating or the need to urinate … Read more

Biotech Stock News (RXII) (MRK) (BMY) (CNAT) (ICPT)

Rxi Pharmaceuticals Corp (NASDAQ: RXII) Rxi Pharmaceuticals last week on March 23, 2015 presented at the 73rd Annual Academy of Dermatology in which the company reported ┬ápositive progress on clinical trial updates for its dermatology programs. The clinical trial with RXI-109-1301 phase 2a enrolled patients to be tested for hypertrophic scars on the abdomen only. … Read more